Queen Margrethe of Denmark has tested positive for COVID-19 for the second time this year, the royal court said on Wednesday. The 82-year-old head of state, who has been on the throne for half a century, has cancelled her appointments for the week. She attended the Queen Elizabeth’s funeral in London on Monday. Queen Margrethe,… Read More Denmark’s Queen Margrethe tests positive for coronavirus
A clash between Nepal’s government and its head of state over controversial citizenship legislation threw the nascent republic into turmoil on Wednesday, after President Bidhya Devi Bhandari refused to sign proposed amendments in the law. The bill proposed, among other changes, to give citizenship certificates to children whose parents’ whereabouts were not known. Under the… Read More Political conflict erupts in Nepal as President Bidhya Devi Bhandari declines to sign amended citizenship law
Walmart and healthcare giant UnitedHealth Group are planning to team up to provide preventive care for people aged 65 and up, and virtual healthcare services for all age groups, the companies said on Wednesday. The 10-year partnership represents Walmart’s latest push into healthcare and could help the retail giant better compete with CVS Health and… Read More Walmart, HealthUnited to partner on preventive healthcare program for seniors
China’s CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country’s drug regulator for emergency use as a booster, potentially benefiting its business. The inhaled version of Cansino’s adenovirus-vectored COVID-19 vaccine has obtained the green light from the National Medical Products Administration, the company said in a… Read More China approves CanSino’s inhaled coronavirus vaccine for emergency use
The U.S. Food and Drug Administration on Wednesday authorized updated COVID-19 booster shots from Pfizer/BioNTech and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a broad fall vaccination campaign that could begin within days. The new vaccines also include the original version of the virus targeted by all… Read More U.S. FDA approves coronavirus vaccines engineered for Omicron variant
Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech U.S.-listed shares were down about 1.5% and Moderna shares slipped 1.7%… Read More Moderna files lawsuit against Pfizer/BioNTech for patent infringement over coronavirus vaccine
Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine retooled to target the Omicron variant. The request to the Food and Drug Administration was for a so-called bivalent vaccine containing the dominant BA.4/BA.5 variants of the virus along with the original coronavirus strain. It is intended… Read More Pfizer seeks U.S. authorization for coronavirus vaccine engineered to tackle Omicron variant
Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus. The UK medicines regulator (MHRA) gave the so-called bivalent vaccine made by U.S. drug company Moderna conditional approval as a… Read More Britain approves vaccine to tackle Omicron coronavirus variant
247NEWSUPDATE BLOG 